Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed

Affiliations

¹ Urology Surgery, The Royal Marsden Hospital, London, UK.
² Department of Urology, St George's University Hospital, London SW17 0QT, UK. Electronic address: rami.issa@nhs.net.
³ Royal Surrey NHS Trust and Faculty of Health and Medical Sciences, University of Surrey, Surrey, UK.

Comment

Rahul Jena et al. Lancet Oncol. 2023 Aug.

. 2023 Aug;24(8):e324.

doi: 10.1016/S1470-2045(23)00321-2.

¹ Urology Surgery, The Royal Marsden Hospital, London, UK.
² Department of Urology, St George's University Hospital, London SW17 0QT, UK. Electronic address: rami.issa@nhs.net.
³ Royal Surrey NHS Trust and Faculty of Health and Medical Sciences, University of Surrey, Surrey, UK.

No abstract available

Conflict of interest statement

We declare no competing interests.

Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.
Zlotta AR, Lajkosz K, Efstathiou JA. Zlotta AR, et al. Lancet Oncol. 2023 Aug;24(8):e325-e326. doi: 10.1016/S1470-2045(23)00322-4. Lancet Oncol. 2023. PMID: 37541276 No abstract available.

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202